Clinical Trials Directory

Trials / Completed

CompletedNCT03181191

The Anatomical Location, Cellular Origin and Molecular Basis of Gut-derived Glucagon Secretion

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University Hospital, Gentofte, Copenhagen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Delineation of the anatomical location, cellular origin and molecular basis of gut-derived glucagon secretion

Detailed description

Aim: to delineate the anatomical origin, the molecular structure and precursors, the regulation and the (patho-) physiological implications of gut-derived glucagon. Eight totally pancreatectomised patients, eight type 2 diabetes patients and eight healthy controls (age 18-80, BMI \<30) with normal kidney and liver parameters and hgb\> 6.5 - will be included. The participants will each undergo one screening day and one study day including a gastroduodenoscopy. Multiple biopsies will be taken at several predefined locations in the upper gastrointestinal tract. These biopsies will be analysed with different techniques including immunohistochemical staining, quantitative polymerase chain reaction (qPCR-) analyses and more to search for glucagon. After the last biopsy has been collected, 50 g of glucose dissolved in 100 ml water is infused through the enteroscope into the most proximal part of the small intestine. Hereafter blood samples for glucagon and gut hormone analyses will be collected 15, 30 and 45 min after the glucose infusion.

Conditions

Interventions

TypeNameDescription
OTHEROral glucose tolerance testOral glucose tolerance test and biopsies

Timeline

Start date
2017-04-27
Primary completion
2017-12-03
Completion
2017-12-03
First posted
2017-06-08
Last updated
2019-09-04

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03181191. Inclusion in this directory is not an endorsement.